Navigation Links
Spine patients who quit smoking report diminished pain

CHICAGO Smoking is a known risk factor for back pain and disc disease. In a new study presented today at the 2013 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), researchers reviewed smoking cessation rates and related pain in 6,779 patients undergoing treatment for spinal disorders with severe axial (spine) or radicular (leg) pain. Information on each patient's age, gender, weight, smoking history, assessment of pain, treatment type and co-morbid depression also were assessed.

Overall, 8.9 percent of patients over the age of 55 smoked compared with 23.9 percent of those aged 55 and younger. Twenty-five percent of the patients older than age 55 had quit smoking, as did 26.1 percent of those younger than age 55.

Current smokers in both age groups reported greater pain than those who had never smoked. Mean improvement in reported pain over the course of treatment was significantly different in non-smokers and current smokers in both age groups.

Those who quit smoking during the course of care reported greater pain improvement than those who continued to smoke. As a group, those who continued smoking during treatment had no clinically significant improvement in reported pain, regardless of age.


Contact: Lauren Pearson Riley
American Academy of Orthopaedic Surgeons

Page: 1

Related biology news :

1. Human-like spine morphology found in aquatic eel fossil
2. Renewal grant supports genetic research into arthritis of the spine
3. Researchers in Manchester find genetic key to preventing spine tumors
4. Spinal tap -- using cactus spines to isolate DNA
5. Reproductive health providers should discuss environmental exposure risks with patients
6. Low-calorie diet may be harmful for bowel disease patients
7. Interventional radiology: Mitigating symptoms, improving quality of life of MS patients
8. Interventional radiologists see significant symptom relief in MS patients
9. Crestor Delivers Latest LDL-C Targets in High-Risk Patients at Lower Doses than Other Statins
10. Tokai Pharmaceuticals galeterone well-tolerated in patients with advanced prostate cancer
11. Obese patients face higher radiation exposure from CT scans -- but new technology can help
Post Your Comments:
(Date:6/15/2016)... York , June 15, 2016 ... new market report titled "Gesture Recognition Market by Application ... Forecast, 2016 - 2024". According to the report, the  ... 11.60 billion in 2015 and is estimated to ... USD 48.56 billion by 2024.  Increasing ...
(Date:6/7/2016)... June 7, 2016  Syngrafii Inc. and San ... relationship that includes integrating Syngrafii,s patented LongPen™ eSignature ... This collaboration will result in greater convenience for ... union, while maintaining existing document workflow and compliance ... ...
(Date:6/2/2016)... , June 2, 2016   The Weather Company ... announcing Watson Ads, an industry-first capability in which consumers will ... being able to ask questions via voice or text and ... Marketers have long sought an ... consumer, that can be personal, relevant and valuable; and can ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
Breaking Biology Technology: